Reck, M. Ciuleanu, T.-E. Lee, J.-S. Schenker, M. Audigier-Valette, C. Zurawski, B. Linardou, H. Otterson, G.A. Salman, P. Nishio, M. de la Mora Jimenez, E. Lesniewski-Kmak, K. Albert, I. Ahmed, S. Syrigos, K. Penrod, J.R. Yuan, Y. Blum, S.I. Nathan, F.E. Sun, X. Moreno-Koehler, A. Taylor, F. O'Byrne, K.J., First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy in Advanced NSCLC With 1% or Greater Tumor PD-L1 Expression: Patient-Reported Outcomes From CheckMate 227 Part 1, Journal of Thoracic Oncology, (16), 665-676, 2021, HANLEY & BELFUS-ELSEVIER INC, 1556-0864, 1556-1380